Clinical trials
Phase 1 Renal Insufficiency trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
226 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 5 |
| 2007 | 4 |
| 2008 | 10 |
| 2009 | 8 |
| 2010 | 6 |
| 2011 | 14 |
| 2012 | 9 |
| 2013 | 11 |
| 2014 | 9 |
| 2015 | 14 |
| 2016 | 12 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 15 |
| 2022 | 18 |
| 2023 | 11 |
| 2024 | 13 |
| 2025 | 12 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 189 |
| Terminated | 18 |
| Recruiting | 9 |
| Active, not recruiting | 5 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 21 |
| AstraZeneca | 12 |
| Merck Sharp & Dohme LLC | 12 |
| Eli Lilly and Company | 11 |
| Novartis Pharmaceuticals | 8 |
| GlaxoSmithKline | 7 |
| Janssen Research & Development, LLC | 6 |
| Amgen | 5 |
| Bristol-Myers Squibb | 5 |
| Celgene | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 226 |
| Kidney Failure, Chronic | 31 |
| Kidney Diseases | 19 |
| Renal Insufficiency, Chronic | 15 |
| Diabetes Mellitus, Type 2 | 6 |
| Multiple Myeloma | 6 |
| Neoplasms | 5 |
| Anemia | 3 |
| COVID-19 | 3 |
| Infections | 3 |
Trials
Showing 1 to 25 of 226. Each trial links to its page on Pharma Observatory.
126 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.